Prudent Precaution in Clinical Trials of Nanomedicines

Journal of Law, Medicine and Ethics 40 (4):831-840 (2012)
  Copy   BIBTEX

Abstract

Medical technologies, including nanomedicine products, are intended to improve health but in many cases may also create their own health risks. Medical products that create their own health risks differ from most other risk-creating technologies in that the very purpose of the medical technology is to prevent or treat health risks. This paradox of technologies intended to reduce existing risks that may have the effect of creating new risks has two conflicting implications. On one hand, we may be more tolerant of health risks from medical technologies because these products are intended to, and often do, reduce overall health risks and improve our health. The health benefits of a medical technology may outweigh the unavoidable adverse effects of that same technology in an individual patient or in the overall treated population.

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,219

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Prudent Precaution in Clinical Trials of Nanomedicines.Gary E. Marchant & Rachel A. Lindor - 2012 - Journal of Law, Medicine and Ethics 40 (4):831-840.
Uncertainty and the ethics of clinical trials.Sven Ove Hansson - 2006 - Theoretical Medicine and Bioethics 27 (2):149-167.
The Research Misconception.Maurie Markman - 2004 - International Journal of Applied Philosophy 18 (2):241-252.
Clinical trials: deliberations on their essence and value.Franz A. Schelling - 2004 - Journal of Evaluation in Clinical Practice 10 (2):291-296.
A clinical trials manual from the Duke Clinical Research Institute: lessons from a horse named Jim.Margaret B. Liu - 2010 - Hoboken, NJ: Wiley-Blackwell. Edited by Kate Davis & Margaret B. Liu.
The protection of patients' rights in clinical trials.Marek Czarkowski - 2006 - Science and Engineering Ethics 12 (1):131-138.
Regulating trust in pediatric clinical trials.Wim Pinxten, Herman Nys & Kris Dierickx - 2008 - Medicine, Health Care and Philosophy 11 (4):439-444.
What makes placebo-controlled trials unethical?Franklin G. Miller & Howard Brody - 2002 - American Journal of Bioethics 2 (2):3 – 9.

Analytics

Added to PP
2016-02-04

Downloads
16 (#855,572)

6 months
6 (#431,022)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

Add more citations

References found in this work

Toward understanding aspects of the precautionary principle.Carl F. Cranor - 2004 - Journal of Medicine and Philosophy 29 (3):259 – 279.
Balancing Uncertain Risks and Benefits in Human Subjects Research.Richard Barke - 2009 - Science, Technology, and Human Values 34 (3):337-364.
Ethics at Phase 0: Clarifying the Issues.Jonathan Kimmelman - 2007 - Journal of Law, Medicine and Ethics 35 (4):727-733.
The precautionary principle and the regulation of U.s. Food and drug safety.Ed Soule - 2004 - Journal of Medicine and Philosophy 29 (3):333 – 350.
Ethics at Phase 0: Clarifying the Issues.Jonathan Kimmelman - 2007 - Journal of Law, Medicine and Ethics 35 (4):727-733.

View all 9 references / Add more references